Darleen Sandoval
Concepts (480)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrectomy | 39 | 2026 | 164 | 9.210 |
Why?
| | Glucagon-Like Peptide 1 | 35 | 2026 | 150 | 7.230 |
Why?
| | Bariatric Surgery | 21 | 2026 | 250 | 5.520 |
Why?
| | Obesity | 52 | 2025 | 3131 | 4.930 |
Why?
| | Glucose | 36 | 2026 | 1053 | 4.840 |
Why?
| | Weight Loss | 28 | 2025 | 858 | 4.310 |
Why?
| | Hypoglycemia | 17 | 2026 | 490 | 3.530 |
Why?
| | Proglucagon | 11 | 2026 | 12 | 3.380 |
Why?
| | Homeostasis | 28 | 2025 | 646 | 3.230 |
Why?
| | Blood Glucose | 47 | 2026 | 2360 | 3.150 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 22 | 2026 | 88 | 3.140 |
Why?
| | Glucagon-Secreting Cells | 6 | 2026 | 25 | 2.980 |
Why?
| | Glucagon | 12 | 2026 | 114 | 2.760 |
Why?
| | Gastric Bypass | 12 | 2026 | 115 | 2.700 |
Why?
| | Eating | 23 | 2025 | 386 | 2.490 |
Why?
| | Gastrointestinal Tract | 6 | 2025 | 203 | 2.170 |
Why?
| | Energy Metabolism | 22 | 2024 | 930 | 2.080 |
Why?
| | Insulin | 39 | 2026 | 2525 | 2.080 |
Why?
| | Pancreas | 7 | 2026 | 343 | 1.980 |
Why?
| | Hypothalamus | 10 | 2018 | 161 | 1.900 |
Why?
| | Animals | 123 | 2026 | 38106 | 1.780 |
Why?
| | Body Weight | 23 | 2021 | 968 | 1.610 |
Why?
| | Diabetes Mellitus, Type 2 | 17 | 2022 | 2623 | 1.610 |
Why?
| | Diet, High-Fat | 17 | 2026 | 267 | 1.450 |
Why?
| | Diabetes Mellitus | 7 | 2021 | 1101 | 1.440 |
Why?
| | Postprandial Period | 9 | 2026 | 114 | 1.290 |
Why?
| | Receptors, Glucagon | 10 | 2019 | 27 | 1.270 |
Why?
| | Mice | 58 | 2026 | 18297 | 1.190 |
Why?
| | Rats | 39 | 2022 | 5586 | 1.160 |
Why?
| | Central Nervous System | 8 | 2014 | 278 | 1.150 |
Why?
| | Solitary Nucleus | 4 | 2023 | 25 | 1.120 |
Why?
| | Brain | 11 | 2025 | 2991 | 1.120 |
Why?
| | Neurons | 11 | 2023 | 1668 | 1.090 |
Why?
| | Intestinal Mucosa | 7 | 2024 | 666 | 1.040 |
Why?
| | Rats, Long-Evans | 18 | 2020 | 126 | 1.040 |
Why?
| | Incretins | 5 | 2017 | 21 | 1.000 |
Why?
| | Hyperglycemia | 6 | 2023 | 384 | 0.940 |
Why?
| | Leptin | 6 | 2020 | 248 | 0.940 |
Why?
| | Glucose Tolerance Test | 15 | 2021 | 360 | 0.890 |
Why?
| | Gastrointestinal Hormones | 2 | 2017 | 4 | 0.860 |
Why?
| | Diet, Fat-Restricted | 3 | 2021 | 79 | 0.860 |
Why?
| | Receptors, Leptin | 4 | 2020 | 25 | 0.850 |
Why?
| | Mice, Inbred C57BL | 23 | 2026 | 6034 | 0.850 |
Why?
| | Food Preferences | 6 | 2017 | 126 | 0.840 |
Why?
| | Mice, Knockout | 24 | 2026 | 3125 | 0.830 |
Why?
| | Bile Acids and Salts | 4 | 2022 | 163 | 0.820 |
Why?
| | Insulin-Secreting Cells | 6 | 2021 | 393 | 0.790 |
Why?
| | Appetite | 1 | 2024 | 80 | 0.780 |
Why?
| | Feeding Behavior | 9 | 2024 | 692 | 0.750 |
Why?
| | Stomach | 6 | 2016 | 106 | 0.720 |
Why?
| | Signal Transduction | 14 | 2026 | 5246 | 0.710 |
Why?
| | Male | 72 | 2026 | 73396 | 0.690 |
Why?
| | Food | 4 | 2017 | 149 | 0.680 |
Why?
| | Intestines | 3 | 2017 | 351 | 0.670 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2023 | 198 | 0.670 |
Why?
| | Gastric Mucosa | 4 | 2025 | 54 | 0.660 |
Why?
| | Gastric Inhibitory Polypeptide | 2 | 2019 | 13 | 0.640 |
Why?
| | Pancreatic Hormones | 1 | 2020 | 3 | 0.630 |
Why?
| | Oleic Acids | 1 | 2020 | 12 | 0.620 |
Why?
| | Ethanolamines | 1 | 2020 | 14 | 0.620 |
Why?
| | Dipeptidyl Peptidase 4 | 2 | 2019 | 15 | 0.620 |
Why?
| | Exercise | 9 | 2006 | 2213 | 0.620 |
Why?
| | Epinephrine | 9 | 2007 | 160 | 0.610 |
Why?
| | Endocannabinoids | 1 | 2020 | 55 | 0.580 |
Why?
| | Duodenum | 3 | 2022 | 76 | 0.580 |
Why?
| | Fasting | 5 | 2021 | 280 | 0.580 |
Why?
| | Appetite Depressants | 3 | 2018 | 19 | 0.580 |
Why?
| | Gene Expression Regulation | 7 | 2020 | 2599 | 0.570 |
Why?
| | Lipid Metabolism | 5 | 2017 | 533 | 0.560 |
Why?
| | Sex Characteristics | 4 | 2019 | 801 | 0.550 |
Why?
| | Liver | 7 | 2021 | 1864 | 0.540 |
Why?
| | Peripheral Nervous System | 1 | 2018 | 20 | 0.540 |
Why?
| | Humans | 68 | 2026 | 146342 | 0.530 |
Why?
| | Inflammation | 5 | 2026 | 2919 | 0.530 |
Why?
| | Hormones | 6 | 2013 | 134 | 0.530 |
Why?
| | Basal Metabolism | 1 | 2018 | 58 | 0.530 |
Why?
| | Metabolism | 1 | 2017 | 44 | 0.520 |
Why?
| | Gastric Emptying | 2 | 2016 | 36 | 0.520 |
Why?
| | Gastroplasty | 4 | 2022 | 31 | 0.490 |
Why?
| | Leadership | 1 | 2021 | 414 | 0.490 |
Why?
| | Diabetes Mellitus, Type 1 | 8 | 2019 | 3930 | 0.480 |
Why?
| | Anorexia | 2 | 2014 | 16 | 0.480 |
Why?
| | Prader-Willi Syndrome | 1 | 2016 | 32 | 0.470 |
Why?
| | N-Acetylglucosaminyltransferases | 2 | 2022 | 25 | 0.470 |
Why?
| | Peptides | 11 | 2022 | 992 | 0.460 |
Why?
| | Jejunum | 1 | 2015 | 36 | 0.460 |
Why?
| | Hyperinsulinism | 7 | 2026 | 115 | 0.450 |
Why?
| | Intestinal Absorption | 1 | 2015 | 103 | 0.440 |
Why?
| | Running | 1 | 2018 | 235 | 0.440 |
Why?
| | Glucose Clamp Technique | 12 | 2015 | 199 | 0.420 |
Why?
| | Apolipoproteins A | 1 | 2014 | 19 | 0.420 |
Why?
| | Disease Models, Animal | 14 | 2021 | 4580 | 0.410 |
Why?
| | Hyperphagia | 1 | 2014 | 37 | 0.410 |
Why?
| | Rhombencephalon | 2 | 2018 | 31 | 0.390 |
Why?
| | Venoms | 6 | 2017 | 22 | 0.390 |
Why?
| | Glucokinase | 1 | 2012 | 15 | 0.380 |
Why?
| | Ribosomal Proteins | 1 | 2013 | 93 | 0.370 |
Why?
| | Vitamin D | 1 | 2016 | 402 | 0.370 |
Why?
| | Malabsorption Syndromes | 2 | 2011 | 14 | 0.360 |
Why?
| | Triglycerides | 5 | 2021 | 527 | 0.360 |
Why?
| | Ileum | 1 | 2013 | 112 | 0.360 |
Why?
| | Adaptation, Physiological | 2 | 2015 | 568 | 0.360 |
Why?
| | Contraceptives, Oral | 2 | 2003 | 37 | 0.350 |
Why?
| | Malnutrition | 1 | 2013 | 87 | 0.350 |
Why?
| | Norepinephrine | 8 | 2007 | 201 | 0.350 |
Why?
| | Estradiol | 2 | 2007 | 517 | 0.350 |
Why?
| | Emotions | 1 | 2017 | 559 | 0.340 |
Why?
| | Insulin Resistance | 5 | 2018 | 1247 | 0.330 |
Why?
| | Lipids | 6 | 2021 | 714 | 0.320 |
Why?
| | Receptor, Melanocortin, Type 4 | 4 | 2019 | 17 | 0.320 |
Why?
| | Hypoglycemic Agents | 10 | 2019 | 1412 | 0.320 |
Why?
| | Liraglutide | 5 | 2018 | 32 | 0.310 |
Why?
| | Toll-Like Receptor 5 | 1 | 2010 | 18 | 0.310 |
Why?
| | Dietary Fats | 7 | 2014 | 307 | 0.310 |
Why?
| | Stress, Physiological | 2 | 2003 | 450 | 0.300 |
Why?
| | Fibroblast Growth Factors | 3 | 2022 | 187 | 0.300 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2010 | 47 | 0.300 |
Why?
| | Dexamethasone | 3 | 2017 | 368 | 0.300 |
Why?
| | Receptors, Somatotropin | 2 | 2021 | 10 | 0.300 |
Why?
| | Neural Pathways | 2 | 2024 | 319 | 0.300 |
Why?
| | Ventromedial Hypothalamic Nucleus | 2 | 2020 | 3 | 0.290 |
Why?
| | Neurosecretory Systems | 2 | 2013 | 31 | 0.290 |
Why?
| | Immune System | 1 | 2010 | 181 | 0.280 |
Why?
| | Nicotine | 1 | 2011 | 337 | 0.280 |
Why?
| | Autonomic Nervous System Diseases | 2 | 2006 | 38 | 0.280 |
Why?
| | Female | 30 | 2026 | 79499 | 0.270 |
Why?
| | Hydrocortisone | 5 | 2005 | 303 | 0.270 |
Why?
| | Enteroendocrine Cells | 2 | 2020 | 7 | 0.270 |
Why?
| | Prosencephalon | 1 | 2007 | 52 | 0.260 |
Why?
| | Arcuate Nucleus of Hypothalamus | 2 | 2021 | 12 | 0.260 |
Why?
| | Autonomic Nervous System | 3 | 2006 | 82 | 0.250 |
Why?
| | Receptors, Glucocorticoid | 2 | 2008 | 132 | 0.250 |
Why?
| | Body Composition | 7 | 2017 | 689 | 0.250 |
Why?
| | Proprotein Convertase 2 | 1 | 2026 | 2 | 0.240 |
Why?
| | Endoplasmic Reticulum-Associated Degradation | 1 | 2026 | 2 | 0.240 |
Why?
| | Gene Expression | 4 | 2020 | 1463 | 0.230 |
Why?
| | Metabolic Syndrome | 1 | 2010 | 364 | 0.230 |
Why?
| | Progesterone | 1 | 2007 | 214 | 0.230 |
Why?
| | Diet | 3 | 2024 | 1273 | 0.230 |
Why?
| | Growth Differentiation Factor 15 | 1 | 2026 | 44 | 0.230 |
Why?
| | Mannitol | 1 | 2025 | 42 | 0.230 |
Why?
| | Rats, Sprague-Dawley | 7 | 2008 | 2537 | 0.230 |
Why?
| | Drug Delivery Systems | 1 | 2009 | 377 | 0.220 |
Why?
| | Serotonin | 2 | 2025 | 297 | 0.220 |
Why?
| | Vagus Nerve | 1 | 2025 | 92 | 0.220 |
Why?
| | Adipose Tissue | 4 | 2021 | 642 | 0.220 |
Why?
| | Muscle, Skeletal | 6 | 2021 | 1818 | 0.210 |
Why?
| | Macrophages | 3 | 2026 | 1532 | 0.210 |
Why?
| | Hypoxia | 2 | 2003 | 1211 | 0.210 |
Why?
| | Adiposity | 4 | 2019 | 533 | 0.210 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2026 | 198 | 0.210 |
Why?
| | Lactic Acid | 2 | 2003 | 295 | 0.200 |
Why?
| | Smoking | 1 | 2011 | 1486 | 0.200 |
Why?
| | Dehydroepiandrosterone Sulfate | 1 | 2004 | 43 | 0.200 |
Why?
| | Adipose Tissue, White | 3 | 2020 | 43 | 0.200 |
Why?
| | Ethanol | 2 | 2007 | 630 | 0.200 |
Why?
| | Anti-Obesity Agents | 1 | 2024 | 67 | 0.190 |
Why?
| | Ghrelin | 2 | 2013 | 42 | 0.190 |
Why?
| | Streptozocin | 1 | 2023 | 22 | 0.190 |
Why?
| | Altitude Sickness | 2 | 2001 | 141 | 0.190 |
Why?
| | Mice, Transgenic | 4 | 2020 | 2134 | 0.180 |
Why?
| | Lipopolysaccharides | 1 | 2026 | 861 | 0.180 |
Why?
| | Estrogen Replacement Therapy | 1 | 2003 | 144 | 0.180 |
Why?
| | Endocrine Glands | 1 | 2002 | 14 | 0.180 |
Why?
| | Lactobacillus | 1 | 2022 | 28 | 0.180 |
Why?
| | Neuronal Plasticity | 1 | 2024 | 312 | 0.170 |
Why?
| | Adipocytes | 3 | 2019 | 223 | 0.170 |
Why?
| | Water-Electrolyte Balance | 1 | 2001 | 37 | 0.170 |
Why?
| | Nucleus Accumbens | 1 | 2022 | 135 | 0.170 |
Why?
| | Pancreatitis | 3 | 1997 | 146 | 0.170 |
Why?
| | Corticosterone | 3 | 2007 | 241 | 0.170 |
Why?
| | Glucagon-Like Peptide-2 Receptor | 2 | 2020 | 16 | 0.170 |
Why?
| | Gastrointestinal Microbiome | 2 | 2019 | 769 | 0.160 |
Why?
| | Energy Intake | 5 | 2018 | 507 | 0.160 |
Why?
| | Circadian Rhythm | 4 | 2019 | 515 | 0.160 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2020 | 39 | 0.160 |
Why?
| | Postoperative Complications | 3 | 2019 | 3034 | 0.160 |
Why?
| | Glutamic Acid | 1 | 2022 | 255 | 0.160 |
Why?
| | Ovariectomy | 1 | 2021 | 164 | 0.160 |
Why?
| | Scavenger Receptors, Class B | 1 | 2020 | 14 | 0.160 |
Why?
| | Glucose Intolerance | 4 | 2014 | 142 | 0.160 |
Why?
| | Receptors, Calcitonin | 1 | 2020 | 3 | 0.160 |
Why?
| | Body Mass Index | 2 | 2021 | 2458 | 0.160 |
Why?
| | PPAR alpha | 1 | 2020 | 56 | 0.150 |
Why?
| | Bromocriptine | 1 | 2019 | 31 | 0.150 |
Why?
| | Proteins | 1 | 2026 | 1022 | 0.150 |
Why?
| | Dopamine Agonists | 1 | 2019 | 41 | 0.150 |
Why?
| | Integrases | 1 | 2020 | 117 | 0.150 |
Why?
| | Anti-Inflammatory Agents | 1 | 2003 | 474 | 0.150 |
Why?
| | Mice, Obese | 2 | 2017 | 68 | 0.150 |
Why?
| | Linagliptin | 1 | 2019 | 5 | 0.150 |
Why?
| | Gene Expression Profiling | 2 | 2019 | 1792 | 0.150 |
Why?
| | Pancreas, Exocrine | 1 | 2019 | 7 | 0.150 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2019 | 46 | 0.140 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2019 | 90 | 0.140 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2019 | 14 | 0.140 |
Why?
| | Gene Knockout Techniques | 1 | 2019 | 122 | 0.140 |
Why?
| | Paraventricular Hypothalamic Nucleus | 2 | 2016 | 34 | 0.140 |
Why?
| | Bone Resorption | 1 | 2019 | 81 | 0.140 |
Why?
| | Cat Diseases | 1 | 2019 | 37 | 0.140 |
Why?
| | Dyslipidemias | 1 | 2020 | 184 | 0.140 |
Why?
| | Cardiovascular System | 3 | 2006 | 137 | 0.140 |
Why?
| | Administration, Oral | 2 | 2020 | 872 | 0.140 |
Why?
| | Cytokines | 1 | 2026 | 2081 | 0.130 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2020 | 233 | 0.130 |
Why?
| | Equidae | 1 | 2017 | 7 | 0.130 |
Why?
| | Bone Marrow Cells | 1 | 2019 | 328 | 0.130 |
Why?
| | Arterivirus Infections | 1 | 2017 | 10 | 0.130 |
Why?
| | Stem Cells | 1 | 2022 | 613 | 0.130 |
Why?
| | Nuclear Proteins | 2 | 2022 | 740 | 0.130 |
Why?
| | Sensation | 1 | 2017 | 56 | 0.130 |
Why?
| | Sexual Maturation | 1 | 2017 | 49 | 0.130 |
Why?
| | Dog Diseases | 1 | 2019 | 140 | 0.130 |
Why?
| | Injections, Intraperitoneal | 1 | 2017 | 115 | 0.120 |
Why?
| | Gene Targeting | 1 | 2017 | 76 | 0.120 |
Why?
| | Up-Regulation | 1 | 2020 | 841 | 0.120 |
Why?
| | Immunohistochemistry | 3 | 2016 | 1712 | 0.120 |
Why?
| | Diterpenes | 1 | 1996 | 26 | 0.120 |
Why?
| | Platelet Activating Factor | 1 | 1996 | 45 | 0.120 |
Why?
| | Testis | 1 | 2017 | 158 | 0.120 |
Why?
| | Physical Conditioning, Animal | 2 | 2016 | 243 | 0.120 |
Why?
| | Dietary Carbohydrates | 2 | 2014 | 146 | 0.120 |
Why?
| | Organ Specificity | 1 | 2017 | 307 | 0.120 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 974 | 0.120 |
Why?
| | Receptors, Calcitriol | 1 | 2016 | 54 | 0.120 |
Why?
| | Cholesterol | 1 | 2018 | 411 | 0.120 |
Why?
| | Electrophysiology | 1 | 2016 | 219 | 0.110 |
Why?
| | Microbiota | 1 | 2022 | 725 | 0.110 |
Why?
| | Lighting | 1 | 2015 | 31 | 0.110 |
Why?
| | Sex Factors | 1 | 2021 | 2107 | 0.110 |
Why?
| | Heterozygote | 2 | 2012 | 311 | 0.110 |
Why?
| | Adult | 14 | 2026 | 41087 | 0.110 |
Why?
| | MicroRNAs | 1 | 2021 | 699 | 0.110 |
Why?
| | Sheep | 1 | 2017 | 870 | 0.100 |
Why?
| | Cell Differentiation | 1 | 2022 | 1982 | 0.100 |
Why?
| | Injections, Intraventricular | 2 | 2004 | 60 | 0.100 |
Why?
| | Receptors, Ghrelin | 1 | 2013 | 7 | 0.100 |
Why?
| | Satiation | 1 | 2013 | 26 | 0.100 |
Why?
| | Diet, Carbohydrate-Restricted | 1 | 2013 | 36 | 0.100 |
Why?
| | Dietary Proteins | 1 | 2014 | 135 | 0.100 |
Why?
| | Testosterone | 1 | 2017 | 419 | 0.100 |
Why?
| | Glucocorticoids | 1 | 2017 | 536 | 0.100 |
Why?
| | Diabetes Complications | 1 | 2014 | 219 | 0.090 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2012 | 13 | 0.090 |
Why?
| | Ribonucleotides | 1 | 2012 | 27 | 0.090 |
Why?
| | Satiety Response | 1 | 2012 | 11 | 0.090 |
Why?
| | Sympathetic Nervous System | 2 | 2004 | 177 | 0.090 |
Why?
| | Sleep Deprivation | 1 | 2015 | 207 | 0.090 |
Why?
| | Oxygen | 1 | 2018 | 997 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 334 | 0.090 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 213 | 0.090 |
Why?
| | Genetic Markers | 1 | 2013 | 340 | 0.090 |
Why?
| | Pulmonary Gas Exchange | 2 | 2003 | 117 | 0.090 |
Why?
| | Electric Stimulation | 1 | 2013 | 273 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 902 | 0.090 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2015 | 265 | 0.090 |
Why?
| | Weight Gain | 2 | 2016 | 562 | 0.090 |
Why?
| | Peptide YY | 1 | 2011 | 28 | 0.090 |
Why?
| | Apoptosis | 4 | 2013 | 2439 | 0.080 |
Why?
| | Models, Animal | 1 | 2013 | 387 | 0.080 |
Why?
| | Exercise Therapy | 1 | 2016 | 488 | 0.080 |
Why?
| | Reference Values | 2 | 2003 | 796 | 0.080 |
Why?
| | RNA, Messenger | 3 | 2017 | 2791 | 0.080 |
Why?
| | Protein Kinases | 1 | 2012 | 311 | 0.080 |
Why?
| | Islets of Langerhans | 1 | 2017 | 852 | 0.080 |
Why?
| | Neutrophils | 1 | 1996 | 1133 | 0.080 |
Why?
| | Intestine, Small | 2 | 2022 | 160 | 0.080 |
Why?
| | Synaptic Transmission | 1 | 2011 | 294 | 0.070 |
Why?
| | Oxygen Consumption | 2 | 2003 | 721 | 0.070 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2009 | 40 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3416 | 0.070 |
Why?
| | Receptors, Nicotinic | 1 | 2011 | 337 | 0.070 |
Why?
| | Bone Marrow | 2 | 2021 | 310 | 0.070 |
Why?
| | HEK293 Cells | 3 | 2017 | 750 | 0.070 |
Why?
| | Phenotype | 1 | 2017 | 3206 | 0.070 |
Why?
| | T-Lymphocytes | 1 | 2017 | 2012 | 0.070 |
Why?
| | Sympathomimetics | 2 | 2005 | 19 | 0.070 |
Why?
| | Appetite Regulation | 1 | 2008 | 31 | 0.070 |
Why?
| | Disease Susceptibility | 1 | 2010 | 339 | 0.070 |
Why?
| | Cell Line, Tumor | 1 | 2016 | 3545 | 0.070 |
Why?
| | Receptors, Mineralocorticoid | 1 | 2008 | 11 | 0.070 |
Why?
| | Infusions, Parenteral | 1 | 2007 | 47 | 0.070 |
Why?
| | Glycolysis | 2 | 2021 | 342 | 0.060 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 158 | 0.060 |
Why?
| | Smoking Cessation | 1 | 2011 | 442 | 0.060 |
Why?
| | Rodentia | 2 | 2019 | 63 | 0.060 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2008 | 154 | 0.060 |
Why?
| | Human Growth Hormone | 2 | 2005 | 46 | 0.060 |
Why?
| | Phenobarbital | 1 | 1986 | 22 | 0.060 |
Why?
| | gamma-Glutamyltransferase | 1 | 1986 | 42 | 0.060 |
Why?
| | Infusions, Intraventricular | 2 | 2017 | 4 | 0.060 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2017 | 665 | 0.060 |
Why?
| | Parietal Cells, Gastric | 1 | 2025 | 2 | 0.060 |
Why?
| | Enterochromaffin-like Cells | 1 | 2025 | 2 | 0.050 |
Why?
| | Proteolysis | 1 | 2026 | 174 | 0.050 |
Why?
| | Gastrins | 1 | 2025 | 8 | 0.050 |
Why?
| | Gastric Acid | 1 | 2025 | 9 | 0.050 |
Why?
| | Polymerase Chain Reaction | 2 | 2019 | 1031 | 0.050 |
Why?
| | Histamine | 1 | 2025 | 52 | 0.050 |
Why?
| | Organ Size | 2 | 2017 | 465 | 0.050 |
Why?
| | Treatment Outcome | 2 | 2016 | 11821 | 0.050 |
Why?
| | Injections, Intravenous | 1 | 2004 | 197 | 0.050 |
Why?
| | Rats, Wistar | 2 | 2016 | 451 | 0.050 |
Why?
| | Endoplasmic Reticulum | 1 | 2026 | 268 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2025 | 533 | 0.050 |
Why?
| | Consciousness | 1 | 2003 | 29 | 0.050 |
Why?
| | Glutamate-Ammonia Ligase | 1 | 2022 | 8 | 0.050 |
Why?
| | Gluconeogenesis | 1 | 2003 | 81 | 0.050 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2026 | 457 | 0.050 |
Why?
| | Infusions, Intravenous | 1 | 2004 | 432 | 0.050 |
Why?
| | Pancreatitis-Associated Proteins | 1 | 2022 | 12 | 0.050 |
Why?
| | Blood Pressure | 3 | 2005 | 1765 | 0.050 |
Why?
| | Heart Rate | 2 | 2005 | 846 | 0.050 |
Why?
| | Differential Threshold | 1 | 2002 | 5 | 0.040 |
Why?
| | Glutamine | 1 | 2022 | 110 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 370 | 0.040 |
Why?
| | Urine | 1 | 2001 | 63 | 0.040 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2022 | 195 | 0.040 |
Why?
| | Amino Acid Transport System y+L | 1 | 2020 | 4 | 0.040 |
Why?
| | Pulmonary Ventilation | 1 | 2001 | 80 | 0.040 |
Why?
| | Absorption, Physiological | 1 | 2020 | 5 | 0.040 |
Why?
| | Epididymis | 1 | 2020 | 14 | 0.040 |
Why?
| | Protein Phosphatase 2C | 1 | 2020 | 15 | 0.040 |
Why?
| | Blood Circulation | 1 | 2020 | 43 | 0.040 |
Why?
| | Respiration | 1 | 2001 | 208 | 0.040 |
Why?
| | Respiratory System | 1 | 2002 | 150 | 0.040 |
Why?
| | Kinetics | 1 | 2004 | 1553 | 0.040 |
Why?
| | Diabetic Angiopathies | 1 | 2002 | 265 | 0.040 |
Why?
| | Ceruletide | 2 | 1997 | 4 | 0.040 |
Why?
| | CLOCK Proteins | 1 | 2019 | 9 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2003 | 1298 | 0.040 |
Why?
| | Exercise Test | 1 | 2003 | 637 | 0.040 |
Why?
| | Prolactin | 1 | 2019 | 88 | 0.040 |
Why?
| | Venezuela | 1 | 2019 | 7 | 0.040 |
Why?
| | Psychodidae | 1 | 2019 | 8 | 0.040 |
Why?
| | Animals, Domestic | 1 | 2019 | 17 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2008 | 1224 | 0.040 |
Why?
| | Diet, Reducing | 1 | 2019 | 90 | 0.030 |
Why?
| | Metabolomics | 1 | 2024 | 738 | 0.030 |
Why?
| | Zoonoses | 1 | 2019 | 39 | 0.030 |
Why?
| | Vesicular Inhibitory Amino Acid Transport Proteins | 1 | 2018 | 10 | 0.030 |
Why?
| | Middle Aged | 3 | 2026 | 36619 | 0.030 |
Why?
| | Cats | 1 | 2019 | 226 | 0.030 |
Why?
| | Vesicular Glutamate Transport Protein 2 | 1 | 2018 | 15 | 0.030 |
Why?
| | Chile | 1 | 2017 | 26 | 0.030 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 32 | 0.030 |
Why?
| | GABAergic Neurons | 1 | 2018 | 38 | 0.030 |
Why?
| | Adenylate Kinase | 1 | 2017 | 26 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2018 | 275 | 0.030 |
Why?
| | Bone Density | 1 | 2021 | 494 | 0.030 |
Why?
| | Acute Disease | 2 | 2000 | 1038 | 0.030 |
Why?
| | Colon | 1 | 2020 | 304 | 0.030 |
Why?
| | Cricetulus | 1 | 2017 | 115 | 0.030 |
Why?
| | CHO Cells | 1 | 2017 | 167 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 366 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2019 | 343 | 0.030 |
Why?
| | Leukocytes | 1 | 2019 | 301 | 0.030 |
Why?
| | CD4-CD8 Ratio | 1 | 2017 | 23 | 0.030 |
Why?
| | Dogs | 1 | 2019 | 517 | 0.030 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 1997 | 162 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 712 | 0.030 |
Why?
| | Pro-Opiomelanocortin | 1 | 2016 | 20 | 0.030 |
Why?
| | Anti-Mullerian Hormone | 1 | 2017 | 62 | 0.030 |
Why?
| | Phosphorylation | 2 | 2018 | 1724 | 0.030 |
Why?
| | Ginkgolides | 1 | 1996 | 4 | 0.030 |
Why?
| | Amylases | 1 | 1996 | 18 | 0.030 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 1997 | 134 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2018 | 408 | 0.030 |
Why?
| | Tyrosine | 1 | 1997 | 217 | 0.030 |
Why?
| | Metformin | 1 | 2020 | 328 | 0.030 |
Why?
| | Antigens, CD19 | 1 | 1997 | 137 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2020 | 587 | 0.030 |
Why?
| | Lactones | 1 | 1996 | 60 | 0.030 |
Why?
| | Catecholamines | 1 | 2016 | 88 | 0.030 |
Why?
| | Lipase | 1 | 1996 | 76 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2018 | 441 | 0.030 |
Why?
| | Adipokines | 1 | 2016 | 56 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 1997 | 284 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2003 | 3647 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 335 | 0.030 |
Why?
| | Altitude | 1 | 2000 | 469 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2018 | 663 | 0.030 |
Why?
| | Pancreatic Ducts | 1 | 1996 | 81 | 0.030 |
Why?
| | Mutation | 2 | 2019 | 4093 | 0.030 |
Why?
| | Nerve Net | 1 | 2018 | 286 | 0.030 |
Why?
| | Peptide Hormones | 1 | 2014 | 11 | 0.030 |
Why?
| | Receptors, Gastrointestinal Hormone | 1 | 2014 | 7 | 0.030 |
Why?
| | Viral Proteins | 1 | 2017 | 351 | 0.030 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 320 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 597 | 0.030 |
Why?
| | Paracrine Communication | 1 | 2014 | 67 | 0.030 |
Why?
| | Cecum | 1 | 2014 | 37 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2017 | 455 | 0.030 |
Why?
| | Transcription Factors | 1 | 2022 | 1730 | 0.020 |
Why?
| | Peripheral Nerves | 1 | 2014 | 73 | 0.020 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2013 | 26 | 0.020 |
Why?
| | Glucose Transporter Type 4 | 1 | 2013 | 39 | 0.020 |
Why?
| | Phylogeny | 1 | 2017 | 924 | 0.020 |
Why?
| | Tamoxifen | 1 | 2014 | 193 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2017 | 509 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 2022 | 0.020 |
Why?
| | Dopamine beta-Hydroxylase | 1 | 2012 | 13 | 0.020 |
Why?
| | Food, Formulated | 1 | 2012 | 16 | 0.020 |
Why?
| | Soybean Oil | 1 | 2012 | 15 | 0.020 |
Why?
| | Emulsions | 1 | 2012 | 58 | 0.020 |
Why?
| | Cues | 1 | 2015 | 326 | 0.020 |
Why?
| | Sucrose | 1 | 2012 | 113 | 0.020 |
Why?
| | Caloric Restriction | 1 | 2013 | 133 | 0.020 |
Why?
| | Intubation, Gastrointestinal | 1 | 2012 | 76 | 0.020 |
Why?
| | Carnitine | 1 | 2012 | 91 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2012 | 193 | 0.020 |
Why?
| | Homozygote | 1 | 2012 | 197 | 0.020 |
Why?
| | B-Lymphocytes | 1 | 1997 | 887 | 0.020 |
Why?
| | Metabolic Networks and Pathways | 1 | 2012 | 175 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2019 | 3017 | 0.020 |
Why?
| | Phospholipids | 1 | 2012 | 215 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2012 | 372 | 0.020 |
Why?
| | Hyperlipidemias | 1 | 2011 | 120 | 0.020 |
Why?
| | Agouti-Related Protein | 1 | 2010 | 3 | 0.020 |
Why?
| | Choice Behavior | 1 | 2012 | 179 | 0.020 |
Why?
| | Neuropeptide Y | 1 | 2010 | 10 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2012 | 379 | 0.020 |
Why?
| | Chronic Disease | 1 | 2016 | 1827 | 0.020 |
Why?
| | Reward | 1 | 2012 | 242 | 0.020 |
Why?
| | Pregnancy | 2 | 2017 | 7230 | 0.020 |
Why?
| | Taste | 1 | 2012 | 237 | 0.020 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2009 | 9 | 0.020 |
Why?
| | Water | 1 | 2012 | 451 | 0.020 |
Why?
| | Behavior, Animal | 1 | 2012 | 531 | 0.020 |
Why?
| | Receptors, CCR2 | 1 | 2008 | 39 | 0.020 |
Why?
| | Chemokine CCL3 | 1 | 2008 | 26 | 0.020 |
Why?
| | Mesentery | 1 | 2008 | 44 | 0.020 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2008 | 66 | 0.020 |
Why?
| | Fludrocortisone | 1 | 2008 | 2 | 0.020 |
Why?
| | Chemokine CCL2 | 1 | 2008 | 112 | 0.020 |
Why?
| | United States | 1 | 2006 | 16136 | 0.020 |
Why?
| | Cell Count | 1 | 2008 | 315 | 0.020 |
Why?
| | Genotype | 1 | 2012 | 1879 | 0.020 |
Why?
| | Piperidines | 1 | 2009 | 225 | 0.020 |
Why?
| | Genetic Variation | 1 | 2012 | 996 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2008 | 397 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1986 | 316 | 0.010 |
Why?
| | Mitochondria | 1 | 2012 | 997 | 0.010 |
Why?
| | Pancreatic Polypeptide | 1 | 2005 | 4 | 0.010 |
Why?
| | Antigens, CD | 1 | 2008 | 560 | 0.010 |
Why?
| | Pyrazoles | 1 | 2009 | 517 | 0.010 |
Why?
| | Calorimetry, Indirect | 1 | 2005 | 72 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2005 | 426 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2005 | 790 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2005 | 693 | 0.010 |
Why?
| | Biopsy | 1 | 2005 | 1075 | 0.010 |
Why?
| | Atmospheric Pressure | 1 | 2000 | 25 | 0.010 |
Why?
| | Drinking | 1 | 2000 | 44 | 0.010 |
Why?
| | Urination | 1 | 2000 | 46 | 0.010 |
Why?
| | Kidney Function Tests | 1 | 2000 | 156 | 0.010 |
Why?
| | Adolescent | 1 | 2019 | 22557 | 0.010 |
Why?
| | Models, Biological | 1 | 2005 | 1761 | 0.010 |
Why?
| | Precipitin Tests | 1 | 1997 | 90 | 0.010 |
Why?
| | Neutralization Tests | 1 | 1997 | 74 | 0.010 |
Why?
| | Cell Compartmentation | 1 | 1997 | 51 | 0.010 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 51 | 0.010 |
Why?
| | Biological Assay | 1 | 1997 | 133 | 0.010 |
Why?
| | Cell Separation | 1 | 1997 | 300 | 0.010 |
Why?
| | Opossums | 1 | 1996 | 9 | 0.010 |
Why?
| | Ligation | 1 | 1996 | 88 | 0.010 |
Why?
| | Rabbits | 1 | 1997 | 651 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1996 | 384 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 846 | 0.010 |
Why?
| | Antibodies | 1 | 1997 | 400 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 1997 | 384 | 0.010 |
Why?
| | Necrosis | 1 | 1996 | 243 | 0.010 |
Why?
| | Cell Death | 1 | 1996 | 379 | 0.010 |
Why?
| | NF-kappa B | 1 | 1997 | 674 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 1997 | 1137 | 0.010 |
Why?
| | DNA Damage | 1 | 1996 | 439 | 0.010 |
Why?
| | Kidney | 1 | 2000 | 1498 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2000 | 2921 | 0.010 |
Why?
| | Protein Binding | 1 | 1997 | 2244 | 0.010 |
Why?
| | Cells, Cultured | 1 | 1997 | 4118 | 0.000 |
Why?
| | DNA | 1 | 1996 | 1421 | 0.000 |
Why?
|
|
Sandoval's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|